Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Pseudomonas aeruginosa type IV fimbriae (T4P) biogenesis machinery is a complex, multi-protein apparatus responsible for the assembly, extension, and retraction of pili on the bacterial surface (Burrows, 2012, Annu Rev Microbiol). This machinery is composed of several functional modules, including the motor ATPases PilB and PilT, the inner membrane platform PilC, and the outer membrane secretin PilQ (Berry & Pelicic, 2015, Nat Rev Microbiol). T4P are critical for virulence as they mediate twitching motility, facilitate initial attachment to host epithelial cells, and contribute to the structural integrity of biofilms (Leighton et al., 2015, J Biol Chem). Because T4P are essential for colonization and persistence but not for basic bacterial growth, they represent a promising target for anti-virulence therapies that exert less selective pressure for resistance than traditional antibiotics (Harvey et al., 2021, Antibiotics). Current research focuses on small molecule inhibitors, such as phenoxyacetanilides, that disrupt the ATPase activity or the assembly of the pilin subunits, effectively disarming the pathogen without killing it (Carter et al., 2017, Proc Natl Acad Sci). Additionally, monoclonal antibodies targeting the major pilin subunit PilA have been explored to block adhesion and promote opsonophagocytosis (DiGiandomenico et al., 2012, Sci Transl Med).
Inhibition of the assembly or retraction of type IV pili by targeting motor ATPases (PilB/PilT), blocking the secretin pore (PilQ), or interfering with pilin subunit (PilA) polymerization and surface presentation.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pseudomonas aeruginosa type IV fimbriae biogenesis machinery (T4P biogenesis machinery).